Navigation Links
ATS Medical Announces Third Quarter 2009 Results
Date:11/2/2009

=======
    ATS Medical, Inc.
    Selected Revenue Information
    (in thousands)
    --------------

                                 Quarter Ended      Nine Months Ended
                                 -------------      -----------------
                             October    September October     September
                                3,          27,       3,          27,
                               2009        2008      2009        2008
                               ----        ----      ----        ----

    Heart valve therapy     $14,163      $11,755   $42,144     $34,529
    Surgical arrhythmia       4,491        4,011    14,117      12,245
    Surgical tools &
     accessories                173          278       750       1,015
                                ---          ---       ---       -----

      Total revenue         $18,827      $16,044   $57,011     $47,789
                            =======      =======   =======     =======



    ATS Medical, Inc.
    Reconciliation of GAAP
     Net Loss to Non-GAAP
     EBITDA
    (Unaudited, in thousands)
    -------------------------

                                      Quarter Ended    Nine Months Ended
                                      -------------    -----------------
                                    October  September October  September
                                       3,       27,       3,       27,
                                      2009     2008     2009      2008
                                      ----     ----     ----      ----



    Net loss, as reported            $(975)  $(3,746) $(2,832) $(10,826)
    Adjustments to net loss:
        Interest expense               648       729    2,081     2,151
        Income tax  expense            132        55      314       284
        Depreciation                   476       494    1,416     1,659
        Amortization of intangibles    812       891    2,412     2,672
                   
'/>"/>
SOURCE ATS Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... to Millennium Research Group (MRG), the global authority ... United States and European transcatheter embolization ... through 2022, with embolization particles representing one of ... drug-eluting beads (DEBs) and radioembolization spheres in interventional ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: PharmaPoint: Atopic ... Analysis to 2022 http://www.reportlinker.com/p01957657/PharmaPoint-Atopic-Dermatitis---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... India Drug Forecast and Market Analysis to ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Drug Delivery Systems -- Focus on End ... STUDY OBJECTIVES A drug ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
(Date:4/23/2014)... Inverse Effects of Midlife Occupational and Leisure Time Physical ... occupational physical activity in midlife increases the risk of ... decreases the risk. This is found in a study ... years. The study was conducted at the Gerontology Research ... Health. , Heavy physical labor is often repetitive, wears ...
(Date:4/23/2014)... depletion of self-control, according to research published in ... Psychological Science. , Self-control can be difficult sticking ... a boring textbook are hard things to do. Considerable ... self-control for a long period seems to "deplete" our ... "It is as if self-control is a limited resource ...
(Date:4/23/2014)... of Alzheimer,s disease has been a rapidly evolving ... the latest crook in the research road, scientists ... between proteins associated with the disease. The report, ... Neuroscience , could have important implications for developing ... and colleagues explain that for years, research has ...
(Date:4/22/2014)... industry leaders visited the New Jersey Institute of ... S. Bloom for the launch of the New ... provides a new model for business innovation through ... assets and investment. U.S. Senator Cory Booker, Panasonic ... Taylor, New Jersey Lieutenant Governor Kim Guadagno, New ...
(Date:4/22/2014)... researchers have characterized a set of clock genes that ... types of species, from flies to humans. Over 15 ... there are more. A team from the Perelman School ... big-data approaches could find them. , To accelerate ... professor of Pharmacology and first author Ron Anafi, MD, ...
Breaking Medicine News(10 mins):Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2Health News:ADHD drug may help preserve our self-control resources 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Bioinformatics profiling identifies a new mammalian clock gene 2
... networks in fruit flies has led researchers to a sensitive ... most common type of kidney cancer. In the journal ... at the University of Chicago shows that the biomarker known ... renal cell carcinomas but not by normal kidney tissue. , ...
... new 30" in groundbreaking new calendarHAGATNA, Guam, Jan. 27 ... natural calendar to promote her "Look Good Naked" theme ... is beautifully captured au natural and semi-nude in high-quality ... in her beautiful cottage home. "I wanted to show ...
... HCA Healthcare announces the following Webcast:, What: ... 10:00 EST, Where: http://www.videonewswire.com/event.asp?id=55052 , How: ... web at the, ... +1-615 344 ...
... Jan. 27 /PRNewswire-FirstCall/ - QLT Inc. ("QLT") (NASDAQ: ... modified "Dutch Auction" tender offer (the "Offer"), which expired at ... on the preliminary report of the depository for the Offer, ... shares (the "Shares") at a price of US$2.50 per Share, ...
... -- The University of Texas at San Antonio (UTSA) ... College of Engineering has been awarded a $199,884, 24-month ... energy combustion. , "This is one of the first ... combustion, gasification and energy efficiency," said Efstathios Michaelides, mechanical ...
... adds affordable, professionally refurbished Hill-Rom hospital beds to its ... ... -- DRE Medical Equipment — named by Business First of Louisville ... refurbished Hill-Rom hospital beds . DRE’s extensive lineup of economically-priced ...
Cached Medicine News:Health News:Roadkill study could speed detection of kidney cancer 2Health News:QLT announces preliminary results of tender offer 2Health News:QLT announces preliminary results of tender offer 3Health News:UTSA receives federal funding for fossil fuel research 2Health News:DRE Medical Equipment Now Sells Reconditioned Hill-Rom Hospital Beds 2Health News:DRE Medical Equipment Now Sells Reconditioned Hill-Rom Hospital Beds 3
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: